DonnaLynnMastermanMD(She/Her)

Vice President, Medical Affairs, Neuroscience Prothena Biosciences

Dr. Masterman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
Prothena Bioscienes
1800 Sierra Point Parkway
Brisbane, CA 94005
Phone+1 805-439-7574

UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Neurology, 1990 - 1993
University of WashingtonInternship, Internal Medicine, 1989 - 1990
University of Washington School of MedicineClass of 1989

PubMed

ADNI Private Partners Scientific Board (PPSB) Diversity, Equity, and Inclusion (DE&I) Working Group: A new collaboration that crosses boundaries for industry, academia...
Ruth Croney, Emil Fristed, Donna Masterman, Martine Meyer, Pallavi Sachdev
Alzheimer's & Dementia. 2024-12-22
1131 citations
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
Xavier Montalban, Stephen L. Hauser, Ludwig Kappos, Douglas L. Arnold, Amit Bar-Or
The New England Journal of Medicine. 2017-01-19
1145 citations
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Stephen L. Hauser, Amit Bar-Or, Giancarlo Comi, Gavin Giovannoni, Hans Peter Hartung
The New England Journal of Medicine. 2017-01-19

Core--ClinincalNational Institute On Aging2004–2008
Trial Of Metrifonate For Treatment Of Probable Alzheimers DiseaseNational Center For Research Resources1999–2001
Donepezil Hydrochloride In Patients W/ DementiaNational Center For Research Resources1999–2001